CLOV icon

Clover Health Investments

3.51 USD
+0.13
3.85%
Updated Apr 23, 1:02 PM EDT
1 day
3.85%
5 days
-5.39%
1 month
-7.87%
3 months
-25.00%
6 months
-7.14%
Year to date
12.14%
1 year
457.23%
5 years
-65.59%
10 years
-65.59%
 

About: Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.

Employees: 570

0
Funds holding %
of 7,419 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

122% more call options, than puts

Call options by funds: $27M | Put options by funds: $12.2M

95% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 20

88% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 33

27% more capital invested

Capital invested by funds: $231M [Q3] → $293M (+$61.3M) [Q4]

12% more funds holding

Funds holding: 157 [Q3] → 176 (+19) [Q4]

2.42% more ownership

Funds ownership: 20.12% [Q3] → 22.55% (+2.42%) [Q4]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$4.50
28%
upside
Avg. target
$4.50
28%
upside
High target
$4.50
28%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
Canaccord Genuity
Richard Close
32% 1-year accuracy
8 / 25 met price target
28%upside
$4.50
Buy
Maintained
3 Mar 2025

Financial journalist opinion

Based on 4 articles about CLOV published over the past 30 days

Neutral
GlobeNewsWire
20 hours ago
Clover Health Announces Changes to Board of Directors
Thomas L. Tran will become Chairman of the Audit Committee and the Nominating and Corporate Governance Committee, and Lee A. Shapiro will not stand for re-election at the 2025 Annual Shareholders' Meeting Thomas L. Tran will become Chairman of the Audit Committee and the Nominating and Corporate Governance Committee, and Lee A. Shapiro will not stand for re-election at the 2025 Annual Shareholders' Meeting
Clover Health Announces Changes to Board of Directors
Neutral
GlobeNewsWire
1 day ago
Clover Health to Participate in Upcoming Investor Conferences
WILMINGTON, Del., April 21, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced its participation in the following investor conferences:
Clover Health to Participate in Upcoming Investor Conferences
Neutral
GlobeNewsWire
2 weeks ago
Clover Health to Report First Quarter 2025 Financial Results on May 6, 2025
WILMINGTON, Del., April 08, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will report first quarter 2025 financial results after market close on Tuesday, May 6, 2025. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on May 6, 2025, to discuss Clover Health's first quarter 2025 business and financial results.
Clover Health to Report First Quarter 2025 Financial Results on May 6, 2025
Neutral
GlobeNewsWire
2 weeks ago
Clover Health Appoints Industry Veteran as Chief Medical Officer of Medicare Advantage
Dr. Shelly Gupta Brings Over a Decade of Medicare Advantage and Healthcare Leadership Experience Dr. Shelly Gupta Brings Over a Decade of Medicare Advantage and Healthcare Leadership Experience
Clover Health Appoints Industry Veteran as Chief Medical Officer of Medicare Advantage
Negative
Seeking Alpha
1 month ago
Clover Health: Expected Margin Contraction Is A Prelude To Exponential Growth
Clover Health Investments' AI capabilities are a major driver for its topline and bottom-line improvements in FY 2024. Clover Health's MCR in Q4 represented a decline from Q3, unlike past years, and rivaled its Q2 MCR, a sign of the impact of its AI capabilities. While Clover expects its margins to contract in FY 2025, its increased investments this year set it up for a highly profitable future starting from FY 2026, in my opinion.
Clover Health: Expected Margin Contraction Is A Prelude To Exponential Growth
Positive
MarketBeat
1 month ago
Missed the Hims & Hers Rally? Clover Health Could Be Next
Shares of Hims & Hers Health Inc. NYSE: HIMS have made a splash in recent weeks, reaching a new all-time high of just under $73 per share. However, a few days later, most of the upside moved right back, crashing down to as low as $36 per share.
Missed the Hims & Hers Rally? Clover Health Could Be Next
Neutral
GlobeNewsWire
1 month ago
Counterpart Health Partners with Google Cloud to Improve Clinical Data Access for Physicians
New functionality within Counterpart Assistant uses Google Cloud's Vertex AI Search to give clinicians comprehensive insights across multiple sources of patient health data New functionality within Counterpart Assistant uses Google Cloud's Vertex AI Search to give clinicians comprehensive insights across multiple sources of patient health data
Counterpart Health Partners with Google Cloud to Improve Clinical Data Access for Physicians
Positive
Zacks Investment Research
1 month ago
CLOV Q4 Earnings Beat Estimates, Sales Miss, Membership Rises
Clover Health's fourth-quarter 2024 results continue to benefit from the strength of its strong member retention. Strong revenue outlook bodes well.
CLOV Q4 Earnings Beat Estimates, Sales Miss, Membership Rises
Neutral
Seeking Alpha
1 month ago
Clover Health Investments, Corp. (CLOV) Q4 2024 Earnings Call Transcript
Clover Health Investments, Corp. (NASDAQ:CLOV ) Q4 2024 Earnings Conference Call February 27, 2025 5:00 PM ET Company Participants Ryan Schmidt - Investor Relations Andrew Toy - Chief Executive Officer Peter Kuipers - Chief Financial Officer Conference Call Participants Jonathan Yong - UBS Tolf Cormanon - Craig Hallam Operator Ladies and gentlemen, good afternoon and welcome to the Clover Health Fourth Quarter and Full Year 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Clover Health Investments, Corp. (CLOV) Q4 2024 Earnings Call Transcript
Positive
Zacks Investment Research
1 month ago
Clover Health Investments, Corp. (CLOV) Tops Q4 Earnings Estimates
Clover Health Investments, Corp. (CLOV) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.07 per share. This compares to loss of $0.12 per share a year ago.
Clover Health Investments, Corp. (CLOV) Tops Q4 Earnings Estimates
Charts implemented using Lightweight Charts™